Results 1 to 10 of about 123,872 (261)
Neuropsychiatric Consequences of Lipophilic Beta-Blockers
Medicina, 2021 Beta-blockers are a class of drugs with important benefits in cardiovascular pathology. In this paper, we aim to highlight their adverse and therapeutic effects in the neuropsychiatric field.
Sabina Alexandra Cojocariu +5 more
doaj +3 more sources
Frontiers in Pharmacology, 2021 Objectives: Rheumatoid arthritis (RA) is an independent nontraditional risk factor for incidence of myocardial infarction (MI) and post-MI outcome is impaired in the RA population.
Sheng-Fu Liu +14 more
doaj +1 more source
International Journal of Cardiology: Heart & Vasculature, 2020 Beta blockers are a recommended therapy in patients with heart failure with reduced ejection fraction(HFrEF). Beta blockers markedly and unequivocally reduce mortality in patients with heart failure with reduced ejection fraction. However, the beneficial
Xizhen Xu, Dao Wen Wang
doaj +1 more source
Journal of Medical Sciences, 2022 Background: Beta-blockers are widely used for the treatment of arrhythmia, hypertension, and congestive heart failure. Major trauma causes significant blood loss and subsequent tachycardia and hypotension.
Jen-Chun Wang +5 more
doaj +1 more source
Pharmaceuticals, 2023 Background: Alzheimer’s disease (AD) is the most common cause of dementia, with a growing number of patients worldwide. The association between AD and treatment with drugs targeting the beta-adrenergic receptor is controversial.
Ali Alghamdi +5 more
doaj +1 more source
BMC Medicine, 2020 Background Beta-blockers are widely used for many cardiovascular conditions; however, their efficacy in contemporary clinical practice remains uncertain.
Oliver J. Ziff +6 more
doaj +1 more source
Die Beta-Adrenerge blokkeermiddels
South African Family Practice, 1980 No abstract available.
Loubie Walters
doaj +1 more source
Beta blockers in traumatic brain injury: a systematic review and meta-analysis
Trauma Surgery & Acute Care Open, 2023 Background Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Beta blockers have shown promise in improving mortality and functional outcomes after TBI. The aim of this article is to synthesize the available clinical data on
Andrew Chen +5 more
doaj +1 more source
Journal of Pharmacoeconomics and Pharmaceutical Management, 2021 Background: Beta-blockers are preferred anti-hypertensive for patients with compelling indications. Vasodilator beta-blockers are of particular benefit in blood pressure control and other cardio-metabolic components with limited disturbance in metabolic
Mende Mensa Sorato +2 more
doaj
Inappropriate use of beta-blockers among medical and dental students at King Saud University, Riyadh
Journal of Family Medicine and Primary Care, 2020 Aim: Self-medication and inappropriate beta-blocker use have been commonly reported among students. This study aimed to determine the prevalence of inappropriate self-prescription of beta-blockers among medical and dental students.
Abdulelah Adnan Abukhalaf +6 more
doaj +1 more source